PLEXION
From Self-sufficiency
| Combination of | |
|---|---|
| Sulfacetamide | Sulfa Antibiotic |
| Sulfur | Keratolytic |
| Clinical data | |
| [[Regulation of therapeutic goods |Template:Engvar data]] | |
| Routes of administration | Topical |
| Legal status | |
| Legal status |
|
PLEXION is a topical acne medication manufactured by Medicis. It combines sodium sulfacetamide, a sulfa antibiotic, and sulfur, a keratolytic agent.[1] It is available in four formulations: as a cleansing cloth, cleanser, topical suspension, and as a facial mask. The sulfacetamide inhibits the growth of the bacterium Propionibacterium acnes that is associated with acne, while sulfur facilitates the removal of dead skin cells to prevent clogged pores.[2]
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />External links
See also
| 40px | This dermatologic drug article is a stub. You can help ssf by expanding it. |
- ↑ "PLEXION (R) (sodium sulfacetamide 10% and sulfur 5%)". Medicis Inc. Retrieved 2008-12-02.
- ↑ "PLEXION Prescribing information" (PDF). Medicis. Retrieved 2008-12-02.
Categories:
- Pages with script errors
- Infobox drug articles with non-default infobox title
- Drugs that are a combination of chemicals
- Infobox drug tracked parameters
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Articles containing unverified chemical infoboxes
- Acne treatments
- Combination drugs
- Pages with broken file links
- Dermatologic drug stubs
- 2Fix
